1. Siavash, J, Andolino, D, Weinberg, V, Missett, B, Law, J, Wara, WM, O’Donnell, RJ, Matthay, KK, Dubois, S, Goldsby, R, Hass-Kogan, D. Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int. J. Radiation Oncology Biol. Phys., Sep 1;75(1):177-82 (2009).
2. Burk, T, Horvai, AE, Gottschalk, A, Leong, SP, Kashani-Sabet, M, Goldsby, R, Law, J, O’Donnell, RJ. Patellar metastatic melanoma in a 13 year old boy. Am J Orthop. Dec;39(12):58206 (2010).
3. Marcus, N, Takada, H, Law, J, Cowan, M, Gil, J, Regueiro, J, Lopez de Sagando, D, Lopez-Granados, E, Dalal, J, Friedrich, W, Manfred, H, Hanson, I, Grunebaum, E, Shearar, W, Roifman, C. Hematopoietic stem cell transplantation for CD3d
Deficiency. J. Allergy and Clinical Immunology, Nov;128(5):1050-7 (2011).
4. Law, J, Cowan, M, Dvorak, C, Baxter-Lowe, L, Musick, L, Horn, B. Busulfan, Fludarabine, and Alemtuzumab as a Reduced Toxicity Regimen for Children with Marrow Stem Cell Defects and Malignancy Improves Engraftment and Graft Versus Host Disease without Delaying Immune Reconstitution. Biology of Blood and Marrow Transplantation; Nov; 18(11):1656-63 (2012).
5. Long-Boyle JR, Savic R, Yan S, Bartelink I, Musick L, French D, Law J, Horn B, Cowan MJ, Dvorak CC. Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use. Therapeutic Drug Monitoring. 2015 Apr;37(2):236-45.
Books and Chapters:
1. Law, J, Matthay, KK. Chapter 66: Hematopoietic Cell Transplant for Neuroblastoma. “Thomas’ Hematopoietic Cell Transplantation, 4th Edition”, Appelbaum, F, et al., Wiley-Blackwell (2009).
View all of Dr. Law’s publications on PubMed.
